Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase III, Randomized, Comparative, Open-label Study of Intravenous Iron Oligosaccharide (Monofer®) Administered by Infusions or Repeated Bolus Injections in Comparison With Oral Iron Sulphate in Inflammatory Bowel Disease Subjects With Iron Deficiency Anaemia

NCT01017614 is registered in ClinicalTrials.gov with Pharmacosmos A/S as lead sponsor.

NCT NCT01017614
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01017614 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase III, Randomized, Comparative, Open-label Study of Intravenous Iron Oligosaccharide (Monofer®) Administered by Infusions or Repeated Bolus Injections in Comparison With Oral Iron Sulphate in Inflammatory Bowel Disease Subjects With Iron Deficiency Anaemia
Lead sponsor
Pharmacosmos A/S
Phase
Phase 3
Overall status
Completed
Start date
October 31, 2009
Completion date
August 31, 2012
Enrollment
350 (estimated)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

inflammatory bowel disease